EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy

Fanti, S, Brigantii, A, Emmett, L, Fizazi , K, Gillessen, S, Goffin, K, Hadaschik, B A, Herrmann, K, Kunikowska, J, Maurer, T, MacLennan, S, Mottet, N, Murphy, D G, Oprea-Lager, D E, O’Sullivan, J M, Oyen, W JG, Rouvière, O, Sartor, O, Stenzl, A, Van Poppel, H, Walz, J, Witjes, W & Bjartell, A 2022, 'EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy', European Urology Oncology, vol. 5, no. 5, pp. 530-536. https://doi.org/10.1016/j.euo.2022.05.003